Delivery Order SPE2DB24D2205-SPE2DB25FEBUG
Award Date
5/1/25
Potential Completion Date
5/2/25
Potential Value
$1.3K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,334.60, is for the delivery of the prescription medication Jolessa 0.15 mg-0.03 mg tablet. The contract is a Delivery Order, with a Firm Fixed Price pricing type, and has an ultimate completion date of May 1, 2023. The contract is not designated as a set-aside award. AmerisourceBergen holds a...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is for the delivery of Jolessa 0.15 mg-0.03 mg tablets, a pharmaceutical product, with a ceiling value of $1,178.45 and a performance period ending on June 26, 2024. The contract is a delivery order under a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that AmerisourceBergen holds with the DLA...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distribution company. The $1,104.25 firm-fixed-price contract is for the supply of Jolessa 0.15 mg-0.03 mg tablets. The contract has an ultimate completion date of April 17, 2024 and is not designated as a set-aside. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued up to $999,999,999.00 through...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Jolessa 0.15 mg-0.03 mg tablets. The $1,109.49 firm fixed-price contract has an ultimate completion date of October 8, 2024. Amerisourcebergen is the prime contractor, and there is no set-aside designation indicated. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical,...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,727.16, is for the delivery of the prescription medication JOLESSA 0.15 MG-0.03 MG TABLET 91S. The contract has an ultimate completion date of September 12, 2022 and is a firm fixed-price contract. AmerisourceBergen Drug Corp is a subsidiary of the parent company Cencora, Inc., which is a...
This is a firm-fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,539.51, is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, to support federal healthcare programs. The contract has an ultimate completion date of October 27, 2023 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award, valued at $1,136.81, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a medical product, and has an ultimate completion date of December 10, 2024. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA Troop Support Medical, valued...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,027.83, is a Delivery Order under an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical. The IDC, valued at $999,999,999, serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The contract is for the delivery of JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product, with a ceiling value of $1,853.46 and a period of performance through March 12, 2024. The award is associated with a larger indefinite delivery contract (IDC) held by...
This is a $1,663.68 delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp's Corporate Office division. The contract is for the delivery of 4565221558 JOLESSA 0.15 MG-0.03 MG TABLET 91S, a pharmaceutical product. This delivery order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment...